Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia

Surovi Hazarika, Michael Angelo, Yongjun Li, Amy J. Aldrich, Shelley I. Odronic, Zhen Yan, Jonathan S. Stamler, Brian H. Annex

Research output: Contribution to journalArticle

Abstract

Objective - In preclinical models of peripheral arterial disease the angiogenic response is typically robust, though it can be impaired in conditions such as hypercholesterolemia and diabetes where the endothelium is dysfunctional. Myoglobin (Mb) is expressed exclusively in striated muscle cells. We hypothesized that myocyte specific overexpression of myoglobin attenuates ischemia-induced angiogenesis even in the presence of normal endothelium. Methods and Results - Mb overexpressing transgenic (MbTg, n=59) and wild-type (WT, n=56) C57B1/6 mice underwent unilateral femoral artery ligation/excision. Perfusion recovery was monitored using Laser Doppler. Ischemia-induced changes in muscle were assessed by protein and immunohistochemistry assays. Nitrite/nitrate and protein-bound NO, and vasoreactivity was measured. Vasoreactivity was similar between MbTg and WT. In ischemic muscle, at d14 postligation, MbTg increased VEGF-A, and activated eNOS the same as WT mice but nitrate/nitrite were reduced whereas protein-bound NO was higher. MbTg had attenuated perfusion recovery at d21 (0.37 ± 0.03 versus 0.47 ± 0.02, P<0.05), d28 (0.40±0.03 versus 0.50±0.04, P<0.05), greater limb necrosis (65.2% versus 15%, P<0.001), a lower capillary density, and greater apoptosis versus WT. Conclusion - Increased Mb expression in myocytes attenuates angiogenesis after hind-limb ischemia by binding NO and reducing its bioavailability. Myoglobin can modulate the angiogenic response to ischemia even in the setting of normal endothelium.

Original languageEnglish (US)
Pages (from-to)2144-2150
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Myoglobin
Muscle Cells
Ischemia
Extremities
Endothelium
Nitrites
Nitrates
Perfusion
Muscles
Proteins
Striated Muscle
Peripheral Arterial Disease
Femoral Artery
Hypercholesterolemia
Vascular Endothelial Growth Factor A
Biological Availability
Ligation
Lasers
Necrosis
Immunohistochemistry

Keywords

  • Angiogenesis
  • Animal models of human disease
  • Endothelium/vascular type/nitric oxide
  • Genetically altered mice

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia. / Hazarika, Surovi; Angelo, Michael; Li, Yongjun; Aldrich, Amy J.; Odronic, Shelley I.; Yan, Zhen; Stamler, Jonathan S.; Annex, Brian H.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, No. 12, 01.12.2008, p. 2144-2150.

Research output: Contribution to journalArticle

Hazarika, Surovi ; Angelo, Michael ; Li, Yongjun ; Aldrich, Amy J. ; Odronic, Shelley I. ; Yan, Zhen ; Stamler, Jonathan S. ; Annex, Brian H. / Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia. In: Arteriosclerosis, thrombosis, and vascular biology. 2008 ; Vol. 28, No. 12. pp. 2144-2150.
@article{5b93ad86913644a7bb9576de06f64f4b,
title = "Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia",
abstract = "Objective - In preclinical models of peripheral arterial disease the angiogenic response is typically robust, though it can be impaired in conditions such as hypercholesterolemia and diabetes where the endothelium is dysfunctional. Myoglobin (Mb) is expressed exclusively in striated muscle cells. We hypothesized that myocyte specific overexpression of myoglobin attenuates ischemia-induced angiogenesis even in the presence of normal endothelium. Methods and Results - Mb overexpressing transgenic (MbTg, n=59) and wild-type (WT, n=56) C57B1/6 mice underwent unilateral femoral artery ligation/excision. Perfusion recovery was monitored using Laser Doppler. Ischemia-induced changes in muscle were assessed by protein and immunohistochemistry assays. Nitrite/nitrate and protein-bound NO, and vasoreactivity was measured. Vasoreactivity was similar between MbTg and WT. In ischemic muscle, at d14 postligation, MbTg increased VEGF-A, and activated eNOS the same as WT mice but nitrate/nitrite were reduced whereas protein-bound NO was higher. MbTg had attenuated perfusion recovery at d21 (0.37 ± 0.03 versus 0.47 ± 0.02, P<0.05), d28 (0.40±0.03 versus 0.50±0.04, P<0.05), greater limb necrosis (65.2{\%} versus 15{\%}, P<0.001), a lower capillary density, and greater apoptosis versus WT. Conclusion - Increased Mb expression in myocytes attenuates angiogenesis after hind-limb ischemia by binding NO and reducing its bioavailability. Myoglobin can modulate the angiogenic response to ischemia even in the setting of normal endothelium.",
keywords = "Angiogenesis, Animal models of human disease, Endothelium/vascular type/nitric oxide, Genetically altered mice",
author = "Surovi Hazarika and Michael Angelo and Yongjun Li and Aldrich, {Amy J.} and Odronic, {Shelley I.} and Zhen Yan and Stamler, {Jonathan S.} and Annex, {Brian H.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1161/ATVBAHA.108.170951",
language = "English (US)",
volume = "28",
pages = "2144--2150",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia

AU - Hazarika, Surovi

AU - Angelo, Michael

AU - Li, Yongjun

AU - Aldrich, Amy J.

AU - Odronic, Shelley I.

AU - Yan, Zhen

AU - Stamler, Jonathan S.

AU - Annex, Brian H.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Objective - In preclinical models of peripheral arterial disease the angiogenic response is typically robust, though it can be impaired in conditions such as hypercholesterolemia and diabetes where the endothelium is dysfunctional. Myoglobin (Mb) is expressed exclusively in striated muscle cells. We hypothesized that myocyte specific overexpression of myoglobin attenuates ischemia-induced angiogenesis even in the presence of normal endothelium. Methods and Results - Mb overexpressing transgenic (MbTg, n=59) and wild-type (WT, n=56) C57B1/6 mice underwent unilateral femoral artery ligation/excision. Perfusion recovery was monitored using Laser Doppler. Ischemia-induced changes in muscle were assessed by protein and immunohistochemistry assays. Nitrite/nitrate and protein-bound NO, and vasoreactivity was measured. Vasoreactivity was similar between MbTg and WT. In ischemic muscle, at d14 postligation, MbTg increased VEGF-A, and activated eNOS the same as WT mice but nitrate/nitrite were reduced whereas protein-bound NO was higher. MbTg had attenuated perfusion recovery at d21 (0.37 ± 0.03 versus 0.47 ± 0.02, P<0.05), d28 (0.40±0.03 versus 0.50±0.04, P<0.05), greater limb necrosis (65.2% versus 15%, P<0.001), a lower capillary density, and greater apoptosis versus WT. Conclusion - Increased Mb expression in myocytes attenuates angiogenesis after hind-limb ischemia by binding NO and reducing its bioavailability. Myoglobin can modulate the angiogenic response to ischemia even in the setting of normal endothelium.

AB - Objective - In preclinical models of peripheral arterial disease the angiogenic response is typically robust, though it can be impaired in conditions such as hypercholesterolemia and diabetes where the endothelium is dysfunctional. Myoglobin (Mb) is expressed exclusively in striated muscle cells. We hypothesized that myocyte specific overexpression of myoglobin attenuates ischemia-induced angiogenesis even in the presence of normal endothelium. Methods and Results - Mb overexpressing transgenic (MbTg, n=59) and wild-type (WT, n=56) C57B1/6 mice underwent unilateral femoral artery ligation/excision. Perfusion recovery was monitored using Laser Doppler. Ischemia-induced changes in muscle were assessed by protein and immunohistochemistry assays. Nitrite/nitrate and protein-bound NO, and vasoreactivity was measured. Vasoreactivity was similar between MbTg and WT. In ischemic muscle, at d14 postligation, MbTg increased VEGF-A, and activated eNOS the same as WT mice but nitrate/nitrite were reduced whereas protein-bound NO was higher. MbTg had attenuated perfusion recovery at d21 (0.37 ± 0.03 versus 0.47 ± 0.02, P<0.05), d28 (0.40±0.03 versus 0.50±0.04, P<0.05), greater limb necrosis (65.2% versus 15%, P<0.001), a lower capillary density, and greater apoptosis versus WT. Conclusion - Increased Mb expression in myocytes attenuates angiogenesis after hind-limb ischemia by binding NO and reducing its bioavailability. Myoglobin can modulate the angiogenic response to ischemia even in the setting of normal endothelium.

KW - Angiogenesis

KW - Animal models of human disease

KW - Endothelium/vascular type/nitric oxide

KW - Genetically altered mice

UR - http://www.scopus.com/inward/record.url?scp=57549109453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57549109453&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.108.170951

DO - 10.1161/ATVBAHA.108.170951

M3 - Article

C2 - 18818418

AN - SCOPUS:57549109453

VL - 28

SP - 2144

EP - 2150

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 12

ER -